Amy Willis - Publications

Affiliations: 
Biostatistics University of Washington, Seattle, Seattle, WA 

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Willis AD, Martin BD. Estimating diversity in networked ecological communities. Biostatistics (Oxford, England). PMID 32432696 DOI: 10.1093/biostatistics/kxaa015  0.335
2018 Tromas N, Taranu ZE, Martin BD, Willis A, Fortin N, Greer CW, Shapiro BJ. Niche Separation Increases With Genetic Distance Among Bloom-Forming Cyanobacteria. Frontiers in Microbiology. 9: 438. PMID 29636727 DOI: 10.3389/Fmicb.2018.00438  0.351
2018 Sahota S, Willis A, Kornhauser N, Ward M, Cobham M, Cigler T, Moore A, Andreopoulou E, Fitzpatrick V, Schneider S, Prima N, Wiener A, Ko D, Laurentiis AD, Warren J, et al. Abstract P1-10-02: A phase II study of copper-depletion using tetrathiomolybdate in patients with breast cancer at high risk for recurrence: Updated results Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P1-10-02  0.331
2017 Sahota S, Kornhauser N, Willis A, Ward MM, Cigler T, Moore A, Andreopoulou E, Fitzpatrick V, Schneider SE, Wiener A, Rubinchik A, Lee S, Lane ME, Mittal V, Vahdat LT. A phase II study of copper-depletion using tetrathiomolybdate (TM) in patients (pts) with breast cancer (BC) at high risk for recurrence: Updated results. Journal of Clinical Oncology. 35: 2557-2557. DOI: 10.1200/Jco.2017.35.15_Suppl.2557  0.323
2016 Chan N, Willis A, Kornhauser N, Ward MM, Lee SB, Nackos E, Seo BR, Chuang E, Cigler T, Moore A, Donovan D, Vallee Cobham M, Fitzpatrick V, Schneider S, Wiener A, et al. Influencing the tumor microenvironment: Phase 2 Study of Copper depletion with tetrathiomolybdate in high risk breast cancer and preclinical models of lung metastases. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27769988 DOI: 10.1158/1078-0432.Ccr-16-1326  0.314
2016 Willis A. Extrapolating abundance curves has no predictive power for estimating microbial biodiversity. Proceedings of the National Academy of Sciences of the United States of America. PMID 27512033 DOI: 10.1073/Pnas.1608281113  0.413
2016 Nackos E, Lee S, Willis A, Kornhauser N, Ward M, Cobham M, Cigler T, Moore A, Fitzpatrick V, Schneider S, Wiener A, Guillaume-Abraham J, Seo BR, Warren JD, Rubinchik A, et al. Abstract LB-349: Copper depletion as a strategy to affect the tumor microenvironment in breast cancer patients at high risk of relapse and in triple negative preclinical models of breast cancer: Updated results of a phase II study of tetrathiomolybdate (TM) in breast cancer (BC) patients (pts) at high risk for recurrence Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-349  0.327
2016 Willis A, Bunge J, Whitman T. Improved detection of changes in species richness in high diversity microbial communities Journal of the Royal Statistical Society: Series C (Applied Statistics). 66: 963-977. DOI: 10.1111/Rssc.12206  0.444
2015 Willis A, Bunge J. Estimating diversity via frequency ratios. Biometrics. 71: 1042-9. PMID 26038228 DOI: 10.1111/Biom.12332  0.311
2015 Nackos EN, Kornhauser N, Ward MM, Cigler T, Moore A, Andreopoulou E, Chan N, Fitzpatrick V, Schneider SE, Wiener A, Warren JD, Rubinchik A, Willis A, Lee S, Lane ME, et al. Altering the tumor microenvironment: A phase II study of copper depletion using tetrathiomolybdate (TM) in patients (pts) with breast cancer (BC) at high risk for recurrence. Journal of Clinical Oncology. 33: 11008-11008. DOI: 10.1200/Jco.2015.33.15_Suppl.11008  0.303
2014 Chan N, Kornhauser N, Ward M, Willis A, Cigler T, Chuang E, Moore A, Donovan D, Schneider SE, Lam C, Warren DJ, Rubinchik A, Rua SH, Lee S, Lane M, et al. Abstract CT309: Influencing the tumor microenvironment: A phase II study of copper-depletion using tetrathiomolybdate (TM) in patients (pts) with breast cancer (BC) at high risk for recurrence Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Ct309  0.323
Show low-probability matches.